Atlas Trials

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

Clinical trial NCT01129648 · COMPLETED

Trial details

NCT number
NCT01129648
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gout
Start date
2010-05-01
Primary completion
2010-11-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.